Cargando…

Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)

Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinior, Beate, Firth, Clair L, Loitsch, Angelika, Stockreiter, Simon, Hutter, Sabine, Richter, Veronika, Lebl, Karin, Schwermer, Heinzpeter, Käsbohrer, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870441/
https://www.ncbi.nlm.nih.gov/pubmed/29363572
http://dx.doi.org/10.1136/vr.104448
_version_ 1783309482402512896
author Pinior, Beate
Firth, Clair L
Loitsch, Angelika
Stockreiter, Simon
Hutter, Sabine
Richter, Veronika
Lebl, Karin
Schwermer, Heinzpeter
Käsbohrer, Annemarie
author_facet Pinior, Beate
Firth, Clair L
Loitsch, Angelika
Stockreiter, Simon
Hutter, Sabine
Richter, Veronika
Lebl, Karin
Schwermer, Heinzpeter
Käsbohrer, Annemarie
author_sort Pinior, Beate
collection PubMed
description Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared with respect to time, type of programme, geographical area and who was responsible for payment. The total costs of the BTV vaccination and surveillance programmes in Austria amounted to €23.6 million, whereas total costs in Switzerland were €18.3 million. Our analysis demonstrates that the costs differed between years and geographical areas, both within and between the two countries. Average surveillance costs per animal amounted to approximately €3.20 in Austria compared with €1.30 in Switzerland, whereas the average vaccination costs per animal were €6.20 in Austria and €7.40 in Switzerland. The comparability of the surveillance costs is somewhat limited, however, due to differences in each nation’s surveillance (and sampling) strategy. Given the importance of the export market for cattle production, investments in such programmes are more justified for Austria than for Switzerland. The aim of the retrospective assessment presented here is to assist veterinary authorities in planning and implementing cost-effective and efficient control strategies for emerging livestock diseases.
format Online
Article
Text
id pubmed-5870441
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58704412018-03-28 Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016) Pinior, Beate Firth, Clair L Loitsch, Angelika Stockreiter, Simon Hutter, Sabine Richter, Veronika Lebl, Karin Schwermer, Heinzpeter Käsbohrer, Annemarie Vet Rec Paper Bluetongue virus (BTV) is an emerging transboundary disease in Europe, which can cause significant production losses among ruminants. The analysis presented here assessed the costs of BTV surveillance and vaccination programmes in Austria and Switzerland between 2007 and 2016. Costs were compared with respect to time, type of programme, geographical area and who was responsible for payment. The total costs of the BTV vaccination and surveillance programmes in Austria amounted to €23.6 million, whereas total costs in Switzerland were €18.3 million. Our analysis demonstrates that the costs differed between years and geographical areas, both within and between the two countries. Average surveillance costs per animal amounted to approximately €3.20 in Austria compared with €1.30 in Switzerland, whereas the average vaccination costs per animal were €6.20 in Austria and €7.40 in Switzerland. The comparability of the surveillance costs is somewhat limited, however, due to differences in each nation’s surveillance (and sampling) strategy. Given the importance of the export market for cattle production, investments in such programmes are more justified for Austria than for Switzerland. The aim of the retrospective assessment presented here is to assist veterinary authorities in planning and implementing cost-effective and efficient control strategies for emerging livestock diseases. BMJ Publishing Group 2018-03-03 2018-01-23 /pmc/articles/PMC5870441/ /pubmed/29363572 http://dx.doi.org/10.1136/vr.104448 Text en © British Veterinary Association (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Paper
Pinior, Beate
Firth, Clair L
Loitsch, Angelika
Stockreiter, Simon
Hutter, Sabine
Richter, Veronika
Lebl, Karin
Schwermer, Heinzpeter
Käsbohrer, Annemarie
Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title_full Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title_fullStr Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title_full_unstemmed Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title_short Cost distribution of bluetongue surveillance and vaccination programmes in Austria and Switzerland (2007–2016)
title_sort cost distribution of bluetongue surveillance and vaccination programmes in austria and switzerland (2007–2016)
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870441/
https://www.ncbi.nlm.nih.gov/pubmed/29363572
http://dx.doi.org/10.1136/vr.104448
work_keys_str_mv AT piniorbeate costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT firthclairl costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT loitschangelika costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT stockreitersimon costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT huttersabine costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT richterveronika costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT leblkarin costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT schwermerheinzpeter costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016
AT kasbohrerannemarie costdistributionofbluetonguesurveillanceandvaccinationprogrammesinaustriaandswitzerland20072016